Track topics on Twitter Track topics that are important to you
Onconova Therapeutics (NASDAQ:ONTX) has announced it has entered into a license agreement with HanX Biopharmaceuticals for the Greater China territory. As quoted in the press release: Under the terms of the agreement, Onconova has granted to HanX (i) an exclusive license to develop and commercialize rigosertib in Greater China and (ii) a non-exclusive license to … Continued
The post Onconova Therapeutics Announces License Agreement with HanX Biopharmaceuticals appeared first on Investing News Network.NEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...